Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Understanding the financial planning life cycle is crucial for making informed financial decisions. Discover the key benefits of mastering this concept.
25,941 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
The Federal Reserve left rates unchanged and signaled a cautious path ahead, as inflation risks and geopolitical tens...
When a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
An unauthorized mint triggered a depeg for Resolv’s stablecoin, with an attacker minting 80 million unbacked tokens a...
A major European energy firm plans to halt offshore wind projects off the U.S. East Coast and redirect about $1B into...
Solana (SOL) sits near the $100 mark, but three brand reasons solana (sol) under $100 point to meaningful upside. Fro...
Geopolitical frictions with Iran are boosting energy and raw-material costs. A prominent downgrade underscores how th...
Friday's session put cybersecurity stocks in retreat as investors priced in AI-driven commoditization risks. Palo Alt...
A little-known international ETF is quietly outperforming the S&P 500 this year, riding a multi-factor strategy and l...
States expand aid to middle-income buyers as mortgage costs and home prices stay elevated. The shift broadens access ...
Crypto traders are weighing ripple (xrp) solana (sol) as summer enters. The rivals push higher, but investors cite di...
Cardano unveils an institutional vault layer designed for tokenized capital on Cardano's chain, signaling a shift awa...